Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Dietary Intake and Body Composition in New Users of the Injectable Contraceptive Depot-Medroxyprogesterone Acetate During the First Year of Use

Full text
Author(s):
Silva dos Santos, Priscilla de Nazare [1] ; Bahamondes, M. Valeria [1] ; Modesto, Waleska Oliveira [1] ; Bahamondes, Luis [1] ; dos Santos Fernandes, Arlete Maria [1]
Total Authors: 5
Affiliation:
[1] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Human Reprod Unit, Campinas, SP - Brazil
Total Affiliations: 1
Document type: Journal article
Source: JOURNAL OF REPRODUCTIVE MEDICINE; v. 62, n. 9-10, p. 526-533, SEP-OCT 2017.
Web of Science Citations: 2
Abstract

OBJECTIVE: To evaluate dietary intake and body composition in new users of the injectable contraceptive depot-medroxyprogesterone acetate (DMPA). STUDY DESIGN: A non-randomized clinical trial. Healthy women (28 DMPA users and 24 copper intrauterine device {[}IUD] users) were paired for age (1 year) and body mass index (BMI) (kg/m(2)) (1). Weight, lifestyle habits, and dietary intake recorded using a 3-day food recall form were evaluated at three-monthly intervals during the first year of use of the method. Body composition was assessed at baseline and at 12 months by dual-energy x-ray absorptiometry. RESULTS: Mean age was 29.6 and 28.6 years in DMPA and IUD users, respectively, while BMI was 23.9 and 24.5 kg/m(2), respectively. An increase of approximately 12% was found in calorie intake (kilocalories/24 h) and in all the macronutrients of the diet in the DMPA group from the third month onwards. There was increase in total lean mass (p<0.046) in the DMPA group and no statistically significant difference in body weight be tween the groups. No association was found between dietary intake and weight gain. CONCLUSION: When initiating use, new DMPA users should be counseled regarding possible changes in dietary intake. (AU)

FAPESP's process: 09/53293-0 - Prospective study for evaluation of the insulin resistance, lipid metabolism and sub clinical cardiovascular disease in women who initiate the depot-medroxyprogesterone acetate (DMP A) contraceptive method with in follow-up for two years. (Project of scientific research)
Grantee:Luis Guillermo Bahamondes
Support Opportunities: Research Grants - Research in Public Policies for the National Health Care System (PP-SUS)